Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0T9DS
|
||||
Former ID |
DIB018205
|
||||
Drug Name |
[35S]TBPS
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [467704] | ||
Structure |
Download2D MOL |
||||
Formula |
C8H15O3PS
|
||||
InChI |
InChI=1S/C8H15O3PS/c1-7(2,3)8-4-9-12(13,10-5-8)11-6-8/h4-6H2,1-3H3/i13+3
|
||||
InChIKey |
VTBHBNXGFPTBJL-DLSVHHIMSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | GABA A receptor | Target Info | Blocker (channel blocker) | [543814] | |
Gamma-aminobutyric-acid receptor alpha-2 subunit | Target Info | Blocker (channel blocker) | [543809] | ||
Gamma-aminobutyric-acid receptor alpha-5 subunit | Target Info | Blocker (channel blocker) | [543811] | ||
Gamma-aminobutyric-acid receptor alpha-3 subunit | Target Info | Blocker (channel blocker) | [543810] | ||
References | |||||
Ref 543809 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 405). | ||||
Ref 543810 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 406). | ||||
Ref 543811 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 408). | ||||
Ref 543814 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 415). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.